Loading…
Loading…
The iShares Global Healthcare ETF is structured to replicate the investment performance of an underlying index, which is comprised of healthcare equities worldwide.
Is IXJ's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
FDA clearance of Lilly and Roche's Alzheimer's blood test highlights a growing diagnostics market and four healthcare ETFs to watch.
The Vanguard Health Care ETF (VHT) is significantly cheaper to own than the iShares Global Healthcare ETF (IXJ). IXJ offers exposure to international companies, while VHT focuses more heavily on the U.S. market.
iShares Global Healthcare ETF offers a 1.4% dividend yield and lower price volatility than State Street SPDR S&P Biotech ETF. State Street SPDR S&P Biotech ETF focuses on U.S. biotechnology, resulting in a higher 1-year total return of 80.2% but a significantly deeper maximum drawdown.
iShares Global Healthcare ETF provides broader diversification with 110 holdings compared to 25 positions in VanEck Biotech ETF VanEck Biotech ETF delivered a 30.8% 1-year total return but has experienced a 39.9% historical maximum drawdown iShares Global Healthcare ETF offers a 1.5% trailing-12-month dividend yield and a longer history since its 2001 launch
IBB delivered 44% returns in one year but swung 40% lower at its worst. IXJ grew steadily with half the volatility and a 1.5% dividend yield.